Correlation Between Tel Aviv and Medivie Therapeutic

Can any of the company-specific risk be diversified away by investing in both Tel Aviv and Medivie Therapeutic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tel Aviv and Medivie Therapeutic into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Tel Aviv 35 and Medivie Therapeutic, you can compare the effects of market volatilities on Tel Aviv and Medivie Therapeutic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tel Aviv with a short position of Medivie Therapeutic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tel Aviv and Medivie Therapeutic.

Diversification Opportunities for Tel Aviv and Medivie Therapeutic

-0.85

Correlation Coefficient

Tel Aviv  Medivie Therapeutic

Pay attention - limited upside

The 3 months correlation between Tel and Medivie is -0.85. Overlapping area represents the amount of risk that can be diversified away by holding Tel Aviv 35 and Medivie Therapeutic in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medivie Therapeutic and Tel Aviv is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tel Aviv 35 are associated (or correlated) with Medivie Therapeutic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medivie Therapeutic has no effect on the direction of Tel Aviv i.e., Tel Aviv and Medivie Therapeutic go up and down completely randomly.

Pair Corralation between Tel Aviv and Medivie Therapeutic

Assuming the 90 days trading horizon Tel Aviv 35 is expected to generate 0.15 times more return on investment than Medivie Therapeutic. However, Tel Aviv 35 is 6.7 times less risky than Medivie Therapeutic. It trades about 0.37 of its potential returns per unit of risk. Medivie Therapeutic is currently generating about -0.06 per unit of risk. If you would invest  202,918  in Tel Aviv 35 on September 23, 2024 and sell it today you would earn a total of  33,519  from holding Tel Aviv 35 or generate 16.52% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Tel Aviv 35  vs.  Medivie Therapeutic

Pair Trading with Tel Aviv and Medivie Therapeutic

The main advantage of trading using opposite Tel Aviv and Medivie Therapeutic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tel Aviv position performs unexpectedly, Medivie Therapeutic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medivie Therapeutic will offset losses from the drop in Medivie Therapeutic's long position.

The idea behind Tel Aviv 35 and Medivie Therapeutic pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.